Word

KHERION

Status

Registered

Status Code

700

Status Date

Tuesday, July 13, 2021

Serial Number

79267807

Registration Number

6413425

Registration Date

Tuesday, July 13, 2021

Mark Type

4000

Filing Date

Thursday, April 4, 2019

Published for Opposition

Tuesday, November 24, 2020

Trademark Owner History

Kherion Technology Limited - Original Registrant

Classifications

5 Pharmaceutical preparations for the treatment and prevention of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, cardiovascular diseases or disorders, metabolic diseases or disorders, inflammation, cancer, and diabetes; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical, medical and veterinary preparations and substances for the treatment and prevention of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, cardiovascular diseases or disorders, metabolic diseases or disorders, inflammation, cancer, and diabetes; pharmaceutical, medical and veterinary preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases or disorders; enzymes for medical and veterinary purposes; vaccines; diagnostic agents, reagents, preparations and substances for pharmaceutical, medical and veterinary purposes; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, blood fraction proteins; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases or disorders, namely, human plasma proteins; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, animal plasma proteins; gene regulatory proteins for medical use; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, antibodies; antibody receptors for medical use; antigens for medical use; antigen receptors for medical use; sanitary preparations for medical and veterinary purposes; preparations for destroying vermin; fungicides, herbicides; molecular components and complexes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

9 Electronic data in recorded form and downloadable electronic publications in the nature of reports, articles, e-books and e-zines relating to enzymes, vaccines, pharmaceuticals and pharmaceutical, medical and veterinary preparations and substances

42 Scientific and technological services and research and design relating thereto relating to enzymes, vaccines, pharmaceuticals and pharmaceutical, medical and veterinary preparations and substances; research in the field of molecular biology; pharmaceutical, medical and veterinary research; industrial analysis in the biological, pharmaceutical, medical, and veterinary fields; industrial research services in the fields of pharmaceuticals, medicine and science; research, development, testing and evaluation of pharmaceuticals and of pharmaceutical, medical and veterinary preparations and substances; research, development, testing and evaluation of enzymes and of diagnostic agents, reagents, preparations and substances for pharmaceutical, medical and veterinary purposes; provision of information and consultancy in relation to any of the aforesaid services

Trademark Events

Nov 15, 2021

Final Decision Transaction Processed By Ib

Oct 24, 2021

Final Disposition Notice Sent To Ib

Oct 23, 2021

Final Disposition Processed

Oct 13, 2021

Final Disposition Notice Created, To Be Sent To Ib

Jul 13, 2021

Registered-Principal Register

Jun 3, 2021

Extension Of Time To Oppose Process - Terminated

Apr 27, 2021

Limitation From The Ib - Request Exam Review

Apr 17, 2021

Limitation Of Goods Received From Ib

Apr 17, 2021

New Representative At Ib Received

Mar 13, 2021

Notification Of Possible Opposition - Processed By Ib

Feb 24, 2021

Notification Of Possible Opposition Sent To Ib

Feb 24, 2021

Notification Of Possible Opposition Created, To Be Sent To Ib

Dec 12, 2020

Notification Processed By Ib

Nov 24, 2020

Extension Of Time To Oppose Received

Nov 24, 2020

Official Gazette Publication Confirmation E-Mailed

Nov 24, 2020

Published For Opposition

Nov 21, 2020

Notification Processed By Ib

Nov 4, 2020

Notification Of Possible Opposition Sent To Ib

Nov 4, 2020

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Nov 4, 2020

Notification Of Notice Of Publication E-Mailed

Oct 19, 2020

Approved For Pub - Principal Register

Oct 16, 2020

Examiner's Amendment Entered

Oct 16, 2020

Notification Of Examiners Amendment E-Mailed

Oct 16, 2020

Examiners Amendment E-Mailed

Oct 16, 2020

Examiners Amendment -Written

May 27, 2020

Notification Of Final Refusal Emailed

May 27, 2020

Final Refusal E-Mailed

May 27, 2020

Final Refusal Written

Apr 28, 2020

Teas/Email Correspondence Entered

Apr 28, 2020

Correspondence Received In Law Office

Apr 28, 2020

Teas Response To Office Action Received

Nov 22, 2019

Refusal Processed By Ib

Nov 2, 2019

Non-Final Action Mailed - Refusal Sent To Ib

Nov 2, 2019

Refusal Processed By Mpu

Oct 16, 2019

Non-Final Action (Ib Refusal) Prepared For Review

Oct 15, 2019

Non-Final Action Written

Oct 5, 2019

Application Filing Receipt Mailed

Oct 1, 2019

Assigned To Examiner

Oct 1, 2019

New Application Office Supplied Data Entered In Tram

Sep 19, 2019

Sn Assigned For Sect 66a Appl From Ib